We are live on ! Find out more
UNH icon

UnitedHealth

3,177 hedge funds and large institutions have $242B invested in UnitedHealth in 2025 Q2 according to their latest regulatory filings, with 277 funds opening new positions, 1,289 increasing their positions, 1,433 reducing their positions, and 654 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more call options, than puts

Call options by funds: $15.3B | Put options by funds: $12.1B

3.46% less ownership

Funds ownership: 88.76%85.3% (-3.5%)

10% less repeat investments, than reductions

Existing positions increased: 1,289 | Existing positions reduced: 1,433

12% less funds holding

Funds holding: 3,6023,177 (-425)

43% less capital invested

Capital invested by funds: $425B → $242B (-$184B)

58% less first-time investments, than exits

New positions opened: 277 | Existing positions closed: 654

68% less funds holding in top 10

Funds holding in top 10: 22673 (-153)

Holders
3,177
Holders Change
-425
Holders Change %
-11.8%
% of All Funds
41.83%
Holding in Top 10
73
Holding in Top 10 Change
-153
Holding in Top 10 Change %
-67.7%
% of All Funds
0.96%
New
277
Increased
1,289
Reduced
1,433
Closed
654
Calls
$15.3B
Puts
$12.1B
Net Calls
+$3.18B
Net Calls Change
+$2.32B
Name Holding Trade Value Shares
Change
Change in
Stake
BMCM
701
Bryn Mawr Capital Management
Pennsylvania
$8.98M -$558K -1,460 -5%
PTB
702
Pioneer Trust Bank
Oregon
$8.92M +$485K +1,270 +5%
PA
703
Parallel Advisors
California
$8.92M -$1.03M -2,702 -9%
RA
704
RFG Advisory
Alabama
$8.91M +$8.9M +23,293 +443%
NSAM
705
North Star Asset Management
Wisconsin
$8.8M +$1.12M +2,919 +12%
AIM
706
Anchor Investment Management
South Carolina
$8.77M +$1.74M +4,556 +19%
WA
707
Waverly Advisors
Alabama
$8.75M -$8.49M -22,201 -44%
BAM
708
Bell Asset Management
Australia
$8.73M +$776K +2,030 +8%
TAM
709
Trillium Asset Management
Massachusetts
$8.7M +$1.09M +2,846 +11%
WS
710
Wedbush Securities
California
$8.69M +$3.66M +9,570 +52%
ET
711
Entropy Technologies
New York
$8.68M +$5.82M +15,221 +121%
LGF
712
LGT Group Foundation
Liechtenstein
$8.62M -$7.78M -20,364 -42%
AWM
713
Apollon Wealth Management
South Carolina
$8.59M -$1.9M -4,968 -15%
SIA
714
Soltis Investment Advisors
Utah
$8.57M +$2.46M +6,437 +31%
HIA
715
Harbor Investment Advisory
Maryland
$8.53M -$1.95M -5,103 -16%
ACIM
716
Azimuth Capital Investment Management
Michigan
$8.5M -$8.96M -23,450 -46%
KCG
717
Kinsale Capital Group
Virginia
$8.48M +$10.4M +27,181 New
HT
718
Heritage Trust
Oklahoma
$8.46M +$90.2K +236 +0.9%
SCA
719
Snowden Capital Advisors
New York
$8.44M -$3.91M -10,231 -27%
DIM
720
Delta Investment Management
California
$8.42M +$7.73M +20,220 +298%
BWS
721
Buck Wealth Strategies
Colorado
$8.39M +$3.17M +8,307 +45%
PIMJS
722
PKO Investment Management Joint-Stock
Poland
$8.39M +$4.97M +12,991 +94%
SWP
723
Stratos Wealth Partners
Ohio
$8.38M +$4.48M +11,717 +77%
HJGA
724
Hardman Johnston Global Advisors
Connecticut
$8.36M -$7.81M -20,426 -43%
MC
725
Middleton & Co
Massachusetts
$8.34M -$99.8K -261 -1%

UNH Hedge Fund Activity: Q2 2025 in Review

3,177 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in UnitedHealth (UNH) for Q2 2025, worth a combined $242B — down 43% from $425B a quarter earlier.

Sellers outnumbered buyers: 654 funds closed out of UNH and 277 opened new positions — a net loss of 377 holders — while 1,433 trimmed existing stakes and 1,289 added.

The largest buyer was Berkshire Hathaway, opening a new position worth an estimated $1.93B. The largest seller was Capital Research Global Investors, cutting an estimated $5.76B.

  • 3,177 institutional investors held UnitedHealth (UNH) as of Q2 2025, down from 3,602 in Q1 2025.
  • Funds reported $242B of UnitedHealth stock for Q2 2025, down 43% quarter-over-quarter.
  • 277 funds opened new UnitedHealth positions in Q2 2025 and 654 closed out, a net change of -377 holders.
  • The largest UnitedHealth buyer in Q2 2025 was Berkshire Hathaway, an estimated $1.93B added.
  • The largest UnitedHealth seller in Q2 2025 was Capital Research Global Investors, an estimated $5.76B sold.

Based on aggregated 13F filings for Q2 2025.